Your session is about to expire
← Back to Search
Mushroom-Based Natural Product for COVID-19 Vaccination (MACH19 Trial)
N/A
Waitlist Available
Led By Andrew Shubov, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Summary
This trial is testing if supplements made from two types of mushrooms can help people getting COVID-19 vaccines by boosting their immune response and reducing side effects.
Who is the study for?
This trial is for adults over 18 who are getting the COVID-19 vaccine and can track their health daily. Participants must not drink alcohol, use cannabis, or consume dairy during the study. People with kidney or liver diseases, as well as pregnant or breastfeeding women, cannot join.
What is being tested?
The trial tests if two mushrooms (Fomitopsis officinalis and Trametes versicolor) can boost the immune response to COVID-19 vaccines. It's a blind test where participants randomly get either the mushroom mix (FoTv) or a placebo without knowing which one they receive.
What are the potential side effects?
Potential side effects of FoTv aren't detailed here but could include typical reactions to supplements such as digestive discomfort, allergic reactions, or changes in energy levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 180 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Alanine transaminase concentration
Albumine concentration
Aspartate transaminase concentration
+6 moreSecondary study objectives
Peripheral Blood Mononuclear Cell (PBMC) immune profiling
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: MushroomsExperimental Treatment1 Intervention
Drug: FoTv The dosage of FoTv is 8 capsules three times a day for 4 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary. Should swallowing capsules be an issue, they can be opened and dispensed into water or juice for easy ingestion.
Group II: PlaceboPlacebo Group1 Intervention
Placebo: organic brown rice The dosage of Placebo is 8 capsules three times a day for 4 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary. Should swallowing capsules be an issue, they can be opened and dispensed into water or juice for easy ingestion.
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,651 Total Patients Enrolled
Andrew Shubov, MDPrincipal InvestigatorUniversity of California, Los Angeles
3 Previous Clinical Trials
214 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You agree to not consume alcohol, cannabis, and dairy products while taking the study medication.
Research Study Groups:
This trial has the following groups:- Group 1: Mushrooms
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.